Q32 Bio (QTTB) Cash & Equivalents Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | -22.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.50% |
| Dec 31, 2025 | -38.05% |
| Sep 30, 2025 | -44.95% |
| Jun 30, 2025 | -43.85% |
| Mar 31, 2025 | -43.31% |
| Dec 31, 2024 | 204.35% |
| Sep 30, 2024 | 145.69% |
| Jun 30, 2024 | 386.94% |
| Mar 31, 2024 | 267.78% |
| Dec 31, 2023 | -24.62% |
| Sep 30, 2023 | -16.00% |
| Jun 30, 2023 | -88.62% |
| Mar 31, 2023 | -87.34% |
| Dec 31, 2022 | -69.20% |
| Sep 30, 2022 | -54.96% |
| Jun 30, 2022 | 49.84% |
| Mar 31, 2022 | 134.77% |
| Dec 31, 2021 | -49.55% |
| Sep 30, 2021 | -46.55% |
| Jun 30, 2021 | -29.86% |
| Mar 31, 2021 | -26.93% |
| Dec 31, 2020 | 297.30% |
| Sep 30, 2020 | 131.15% |
| Jun 30, 2020 | 43.47% |
| Mar 31, 2020 | 243.47% |
| Dec 31, 2019 | 37.65% |
| Sep 30, 2019 | 105.03% |
| Jun 30, 2019 | 23.04% |
| Mar 31, 2019 | -12.24% |
| Dec 31, 2018 | -25.03% |
| Sep 30, 2018 | -61.31% |
| Jun 30, 2018 | 364.81% |
| Mar 31, 2018 | 81.09% |